FORWARD FEATURES CALENDAR

Find us on

Latest News

Webster Capital (Webster) has held the final closing of its latest fund, Webster Capital IV at its hard cap of USD875 million, exceeding its initial target of USD650 million. The fund will allow Webster to continue to pursue its successful strategy of investing in branded consumer and healthcare service companies across the North American lower middle market.   The fundraising was oversubscribed and received commitments from both new and returning limited partners, including leading institutions from Europe, North America, Asia and Australia. Webster’s previous fund, Webster Capital III, closed in 2015 on USD416 million.   Webster IV has already made
Mohammad Alardhi, Investcorp
Investcorp, a provider and manager of alternative investment products, has made a strategic minority investment in Banque Pâris Bertrand Sturdza, an independent, Swiss-regulated private bank based in Geneva and Luxembourg. The Bank has experienced strong growth since its establishment in Geneva in May 2009, growing its assets under management (AUM) at an average yearly growth rate of 35 per cent to CHF 5.3 billion (USD5.4 billion) as of June 2018. The Bank provides independent investment advice and customised investment solutions to over 400 high-net-worth individuals, family offices and institutional clients mainly from Switzerland and Europe.   The Bank was recognised
Mesirow Financial has acted as the exclusive financial advisor to Adams Manufacturing Corp on its sale to Keter Group (Keter), a portfolio company of BC Partners. Adams is a manufacturer of injection moulded consumer products. The company’s product portfolio includes resin garden furniture and accessories, suction cups and Christmas decorating hardware and accessories for residential and commercial markets.   William E Adams, III, founder of Adams, says: “We are grateful for what our wonderful associates have accomplished at Adams over the last 40 years. Partnering with Keter is a unique opportunity for Adams to accelerate its development. Mesirow Financial advised
King & Spalding has appointed Amy Peters as a partner in the firm’s Corporate, Finance and Investments practice group in its Chicago office.   Peters will focus on representing credit funds, banks, investors and borrowers in a variety of leveraged finance transactions, as well as recapitalisations, workouts and restructurings.   “Amy adds depth to our finance bench, and will enhance our relationships with credit funds and other lender clients, particularly those based in Chicago,” says Carolyn Alford, lead of the Financial Services practice. “Amy also brings tremendous depth of experience in representing private equity funds and corporate clients in complex
Auxo Investment Partners, a Michigan-based private equity firm, has held the final closing of its first investment fund, Auxo Growth Holdings I with USD50 million in committed capital from family offices and institutional investors. Auxo was founded in late 2016 by three veteran investors and operators: Jeff Helminski, Jack Kolodny and Fred Tedori. Combined with direct co-investment from family offices and modest leverage, the inaugural fund will deploy approximately USD150 million of equity in 10 to 15 companies over the next three years – and has already invested over USD30 million of equity in four acquisitions, including a die-manufacturing platform
Dominic Wheatley, Guernsey Finance
The total value of funds business in Guernsey is at a five-year high following a predicted rise in net asset value in Q2 2018, according to the latest figures from the Guernsey Financial Services Commission. The figures for the end of June 2018 showed the net asset value stood at GBP276.2 billion, the highest since the end of June 2013, and a growth of more than GBP13 billion (4.94 per cent) on Q1 2018 and a 12-month growth of more than GBP5 billion (1.9 per cent).   Private equity business was a huge contributor, with a near GBP7 billion (6.6
Geoff Cook, Jersey Finance
After almost 12 years in the role, Geoff Cook has decided to step down from his role as Chief Executive of Jersey Finance, the promotional body for the Jersey finance industry. Appointed in 2007, Cook (pictured), has been at the helm of the organisation, helping guide the island through the financial crisis of 2007/8 and playing a key role over the last decade in driving Jersey forward as an international finance centre of excellence.   He will remain in his position as CEO throughout his notice period. The Board is already engaged with the Appointments Commission in terms of advertising
Renewable energy infrastructure investors Aurium Capital Markets (Aurium), Equitix and Helios Energy Investments (Helios) have formed a new dedicated business to invest in renewable energy plants which use anaerobic digestion (AD) technology.  The newly formed Bio Capital is developing a portfolio of AD plants in the UK and Ireland, targeting operational and greenfield assets, and comprising both gas-to-grid and electricity generation facilities that utilise food-waste and agri-feedstock fuel sources.   The business has already completed its first transaction, acquiring the largest operational AD plant in Scotland from Energen Biogas, a joint venture of Renewi plc (LSE: RWI) and Paragon Efficiencies.
BGF has provided GBP6 million funding to One Media iP Group, a digital media content provider that primarily exploits music intellectual property rights. The AIM listed company, which is based in Pinewood Studios, will use the funding to support the acquisition of music catalogues as part of its buy and build growth strategy.   BGF’s funding follows the Board appointments earlier this year of Ivan Dunleavy, former CEO of Pinewood Studios and current non-executive chair of BGF-backed Milk Visual Effects, and Lord Michael Grade, formerly Chair of BBC, executive chair of ITV and CEO of Channel 4. The company employs
Private equity investment firm HIG Capital (HIG) has completed the sale of its portfolio company AMPAC Fine Chemicals (AFC) to SK Holdings Co Ltd. Based in Rancho Cordova, California, AFC is a global supplier of high value-added active pharmaceutical ingredients and intermediates used in treating diseases such as cancer, CNS disorders and various viral infections. AFC is strategically located with four facilities within the United States and has over USD200 million of revenue. The Company provides services to a large number of blue chip pharmaceutical and biotech companies throughout the entire life cycle of their products.   HIG acquired AFC

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings